Commentary

Wholesalers Face Pressing Need to Retool Biz Strategy as Generics Gain Ground

Lexicon

Pricing premium for the promotion of new drug development and the elimination/resolution of off-label use:
新薬創出・適応外薬解消等促進加算(新薬創出加算)

The Column

What’s Your Pharma Company’s Brand in Japan?

Archives

Wholesalers Must Ponder Use of Reps for New Business: Mediceo CEO(Jul.31)
Nichi-Iko to Tie Up with Thai Drug Maker to Strengthen Lineup, Accelerate Brand Penetration(Jul.31)
Nippon Kayaku Initiates PIII Study of Herceptin Biosimilar in Japan(Jul.31)
Sumitomo Dainippon’s Leigh Syndrome Drug Showed No Statistical Difference in PIIb Study in US(Jul.31)
Cresemba Fails to Meet Primary Endpoint in PIII Study for Candidemia: Astellas(Jul.31)

News Calendar